ArticleDevelopmental medicine and child neurology2026
The Pediatric Screening-Priority Evaluation Dysphagia: Validation of a new tool for screening swallowing disorders in infants and children.
Article in Developmental medicine and child neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Evaluating a novel tool for screening pediatric aspiration and penetration risk: Considerations for safe and effective dysphagia screening in children.Developmental medicine and child neurology · 2026Article
- Feeding and swallowing function and dysphagia risk in children with posterior fossa tumors: a preliminary Italian cohort study.Frontiers in oncology · 2026Article
- The Pediatric Screening-Priority Evaluation Dysphagia: Validation of a new tool for screening swallowing disorders in infants and children.Developmental medicine and child neurology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
aimTo assess the psychometric properties of the Pediatric Screening-Priority Evaluation Dysphagia (PS-PED), a novel 14-item, non-invasive tool for identifying dysphagia risk in infants and children.
methodInternal consistency and interrater reliability were evaluated using Cronbach's alpha and intraclass correlation coefficient (ICC). Concurrent validity was assessed by correlating PS-PED scores with the Penetration Aspiration Scale (PAS). Analysis of variance examined score differences across neurological and neuromuscular conditions, congenital and musculoskeletal abnormalities, cardiovascular disease, and genetic syndromes. Receiver operating characteristic (ROC) curves determined cut-offs for optimal sensitivity and specificity.
resultsThe PS-PED was administered to 117 children (59 males and 58 females; mean age 6 years 8 months, SD 4 years 4 months), showing good internal consistency (Cronbach's alpha = 0.716) and strong interrater reliability (ICC = 1). A positive correlation (0.765) was found with the PAS, with significant score differences among diagnostic groups. ROC analysis established cut-offs for two dysphagia risk levels.
interpretationThe PS-PED is a reliable, valid screening tool for dysphagia, facilitating early identification in infants and children across various medical conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.